During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...

Members of the Leukemia and Lymphoma Society discussed the importance of educating others, fundraising and spreading ...

Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...

New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

With so many holidays, awareness days, education weeks, and heritage months happening all year long, we’ve been slowly ...